mirtazapine has been researched along with olanzapine in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 24 (57.14) | 29.6817 |
2010's | 14 (33.33) | 24.3611 |
2020's | 4 (9.52) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alonso, JM; Andrés, JI; Cid, JM; Díaz, A; Fernández, J; Gil, P; Iturrino, L; Megens, A; Sipido, VK; Trabanco, AA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Murphy, T; Nguyen, M | 1 |
Duggal, HS; Fetchko, J | 1 |
Danileviciūte, V | 1 |
Davis, MP; Khawam, E; Lagman, R; Pozuelo, L | 1 |
Canale, A; Crucitti, D; D'Arrigo, C; Malara, G; Muscatello, MR; Spina, E; Torre, DL; Zoccali, R | 1 |
Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
Heiser, P; Krieg, JC; Singh, S; Vedder, H | 1 |
Chou, YH; Shiah, IS; Wang, TS | 1 |
Appel, H; Fiedler, U; Jockers-Scherübl, MC; Klein, JP; Quante, A | 1 |
Chandra, PS; Chaturvedi, SK; Gupta, A; Prabhu, SC; Ranjan, S | 1 |
Fountoulakis, KN; Iacovides, A; Kaprinis, GS; Koumaris, V; Siamouli, M | 1 |
Hulstijn, W; Ruigt, GS; Sabbe, BG; Verkes, RJ; Wezenberg, E | 1 |
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
Foley, KF; Kast, RE | 1 |
Conrad, R; Geiser, F; Imbierowicz, K; Liedtke, R; Wegener, I | 1 |
Bahk, WM; Chae, JH; Jun, TY; Jung, YE; Seo, HJ; Woo, YS | 1 |
Iacovides, A; Kaprinis, G; Nimatoudis, J; Sokolaki, S; Spyridi, S | 1 |
Lin, D; Lin, GY; Pan, XJ; Wang, XB; Wang, XQ; Wu, JZ; Xiang, Z | 1 |
Heres, S; Laika, B; Leucht, S; Schneider, H; Steimer, W | 1 |
Adomaitiene, V; Danileviciūte, V; Fokas, V; Gumbrevicius, G; Sveikata, A; Sveikatiene, R | 1 |
Fisar, Z; Hroudová, J; Raboch, J | 1 |
Christoffersen, RK; Høimark, L; Vesterby, A; Vestergård, LD | 1 |
Bertolino, A; Blasi, G; Caforio, G; De Simeis, G; Di Giorgio, A; Fazio, L; Mancini, M; Nardini, M; Rampino, A; Rizzo, M; Romano, R; Taurisano, P; Ursini, G | 1 |
Buggenhout, S; Sienaert, P; Vandenberghe, J | 1 |
Abe, M; Fukudo, S; Ichie, M; Machida, T; Otera, M | 1 |
Khouzam, HR | 1 |
Ong, CT; Sung, SF; Tong, SH; Wu, CS | 1 |
Abreu, T; Barranha, R; Freitas, C; Von Doellinger, O | 1 |
Furukawa, F; Hashizume, Y; Hata, S; Ishida, Y; Ishigami, A; Kawaguchi, M; Kimura, A; Kondo, T; Kuninaka, Y; Nosaka, M; Ozaki, M; Shimada, E; Takayasu, T; Yamamoto, H | 1 |
Koziorowski, M; Mytych, J; Sołek, P; Tabęcka-Łonczyńska, A | 1 |
Hefner, G; Klimke, A; Reißner, P; Toto, S; Wolff, J | 1 |
Osler, M; Rosenqvist, TW; Wium-Andersen, IK; Wium-Andersen, MK | 1 |
5 review(s) available for mirtazapine and olanzapine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Drug Interactions; Humans; Mianserin; Mirtazapine; Neoplasms; Olanzapine; Palliative Care; Pirenzepine | 2002 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report.
Topics: Acute Disease; Acute Kidney Injury; Adult; Benzodiazepines; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Pulmonary Edema; Rhabdomyolysis; Serotonin Syndrome | 2015 |
5 trial(s) available for mirtazapine and olanzapine
Article | Year |
---|---|
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
Topics: Adult; Affect; Antipsychotic Agents; Arousal; Benzodiazepines; Choice Behavior; Cross-Over Studies; Double-Blind Method; Female; Haloperidol; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Memory Disorders; Mianserin; Mirtazapine; Olanzapine; Psychological Tests; Psychomotor Performance; Reaction Time; Reference Values; Saccades; Surveys and Questionnaires; Verbal Learning | 2007 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 2009 |
Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Chlorprothixene; Controlled Clinical Trials as Topic; Data Collection; Data Interpretation, Statistical; Depression; Female; Humans; Lithuania; Male; Mental Health Services; Mianserin; Middle Aged; Mirtazapine; Observation; Olanzapine; Primary Health Care; Psychiatric Status Rating Scales; Remission Induction; Tablets; Time Factors; Treatment Outcome | 2009 |
Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2013 |
32 other study(ies) available for mirtazapine and olanzapine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Furans; Heterocyclic Compounds, 4 or More Rings; Humans; In Vitro Techniques; Mice; Psychotropic Drugs; Radioligand Assay; Rats; Stereoisomerism; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Mirtazapine for excessive masturbation in an adolescent with autism.
Topics: Adolescent; Adrenergic alpha-Antagonists; Autistic Disorder; Benzodiazepines; Drug Therapy, Combination; Humans; Male; Masturbation; Mianserin; Mirtazapine; Olanzapine; Pirenzepine; Remission Induction; Selective Serotonin Reuptake Inhibitors | 2001 |
Serotonin syndrome and atypical antipsychotics.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Pirenzepine; Schizophrenia; Schizotypal Personality Disorder; Serotonin Syndrome; Tramadol | 2002 |
Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Italy; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells.
Topics: Actins; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Blood Cells; Clozapine; Glucose Transporter Type 3; Glucose Transporter Type 4; Glucose Transporter Type 5; Haloperidol; Humans; Mianserin; Mirtazapine; Olanzapine; RNA, Messenger; U937 Cells | 2006 |
Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Antiemetics; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Olanzapine | 2006 |
Massive creatine kinase elevations with quetiapine: report of two cases.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Creatine Kinase; Depressive Disorder, Major; Dibenzothiazepines; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Pain; Psychotic Disorders; Quetiapine Fumarate | 2006 |
Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Risperidone; Serotonin Antagonists; Treatment Outcome | 2006 |
Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
Topics: Adult; Anorexia; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors | 2006 |
Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Cachexia; Humans; Mianserin; Mirtazapine; Nausea; Neoplasms; Olanzapine; Ondansetron; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists | 2007 |
Nature against nurture: calcification in the right thalamus in a young man with anorexia nervosa and obsessive-compulsive personality disorder.
Topics: Adult; Anorexia Nervosa; Benzodiazepines; Calcinosis; Combined Modality Therapy; Dominance, Cerebral; Humans; Life Change Events; Male; Mediodorsal Thalamic Nucleus; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Psychotherapy; Thalamic Diseases; Tomography, X-Ray Computed | 2008 |
Status epilepticus in a patient treated with olanzapine and mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Drug Interactions; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Psychotic Disorders; Status Epilepticus | 2009 |
[Simultaneous determination of clozapine, olanzapine and mirtazapine in human plasma by LC-MS/MS].
Topics: Benzodiazepines; Chromatography, Liquid; Clozapine; Forensic Toxicology; Humans; Mianserin; Mirtazapine; Olanzapine; Tandem Mass Spectrometry | 2009 |
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.
Topics: Adult; Aged; Benzodiazepines; Cytochrome P-450 CYP1A2; Depressive Disorder; Female; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Pharmacogenetics; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Schizophrenia; Smoking; Weight Gain | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
[Eosinophilic myocarditis and sudden unexpected death in a younger patient treated with antipsychotics].
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Autopsy; Benzodiazepines; Death, Sudden, Cardiac; Drug Therapy, Combination; Eosinophilia; Forensic Pathology; Forensic Toxicology; Humans; Male; Mianserin; Mirtazapine; Myocarditis; Myocardium; Olanzapine; Piperazines; Quinolones; Risk Factors | 2011 |
[Electroconvulsion therapy for neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neuroleptic Malignant Syndrome; Olanzapine | 2014 |
Pharmacological and psychosomatic treatments for an elderly patient with severe nausea and vomiting in reaction to postoperative stress.
Topics: Aged; Amoxapine; Anti-Anxiety Agents; Antidepressive Agents; Antiemetics; Benzodiazepines; Bromazepam; Clomipramine; Combined Modality Therapy; Female; Humans; Mianserin; Mirtazapine; Nausea; Olanzapine; Physical Therapy Modalities; Postoperative Complications; Psychotherapy; Stomach Neoplasms; Stress, Psychological; Vomiting | 2015 |
[Mirtazapine-Induced Mania: A Case Report].
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Middle Aged; Mirtazapine; Olanzapine; Psychoses, Substance-Induced | 2019 |
A case of complex suicide due to acute nicotine intoxication caused by cigarette ingestion.
Topics: Adult; Autopsy; Blood Chemical Analysis; Caffeine; Cotinine; Forensic Toxicology; Gastrointestinal Contents; Humans; Male; Mirtazapine; Nicotine; Olanzapine; Suicide, Completed | 2020 |
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxetine; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Imipramine; Male; Mice; Micronuclei, Chromosome-Defective; Mirtazapine; Models, Biological; Olanzapine; Organ Specificity; Reboxetine; Reproduction; Signal Transduction; Spermatogenesis; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2; Time Factors; Venlafaxine Hydrochloride | 2021 |
Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Female; Humans; Male; Mental Disorders; Middle Aged; Mirtazapine; Off-Label Use; Olanzapine; Psychiatry; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone; Valproic Acid | 2022 |
Sedative drug-use in Denmark, 2000 to 2019: a nationwide drug utilization study.
Topics: Benzodiazepines; Denmark; Drug Prescriptions; Drug Utilization; Female; Humans; Hypnotics and Sedatives; Male; Melatonin; Mianserin; Mirtazapine; Olanzapine; Pregabalin; Promethazine; Quetiapine Fumarate; Substance-Related Disorders | 2023 |